Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts.
Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
J Am Coll Radiol. 2023 Oct;20(10):1031-1041. doi: 10.1016/j.jacr.2023.05.015. Epub 2023 Jul 3.
Incidentally detected gallbladder polyps are commonly encountered when performing upper abdominal ultrasound. Our purpose was to estimate the life expectancy (LE) benefit of ultrasound-based gallbladder surveillance in patients with small (6-7 to <10 mm), incidentally detected gallbladder polyps, accounting for patient sex, age, and comorbidity level.
We developed a decision-analytic Markov model to evaluate hypothetical cohorts of women and men with small gallbladder polyps, with varying age (66-80 years) and comorbidity level (none, mild, moderate, severe). Drawing from current evidence, in the base case, we assumed no increased risk of gallbladder cancer in patients with small gallbladder polyps. To estimate maximal possible LE gains from surveillance, we assumed perfect cancer control consequent to 5 years of surveillance. We varied key assumptions including cancer risk and test performance characteristics in sensitivity analysis.
Projected LE gains from surveillance were <3 days across most cohorts and scenarios evaluated. For 66- and 80-year-olds with no comorbidities, LE gains were 1.46 and 1.45 days, respectively, for women, and 0.67 and 0.75 days for men. With 10 years of surveillance, LE gains increased to 2.94 days for 66-year-old women with no comorbidities (men: 1.35 days). If we assumed a 10% increase in gallbladder cancer risk among individuals with polyps, LE gains increased slightly to 1.60 days for 66-year-old women with no comorbidities (men: 0.74 days). Results were sensitive to test performance and surgical mortality.
Even under unrealistic, optimistic assumptions of cancer control, ultrasound surveillance of incidentally detected small gallbladder polyps provided limited benefit.
在上腹部超声检查时,偶然发现的胆囊息肉较为常见。我们的目的是估计基于超声的胆囊监测对偶然发现的小(6-7 至<10 毫米)胆囊息肉患者的预期寿命(LE)获益,同时考虑患者的性别、年龄和合并症水平。
我们开发了一个决策分析马尔可夫模型,以评估具有不同年龄(66-80 岁)和合并症水平(无、轻度、中度、重度)的女性和男性小胆囊息肉患者的假设队列。根据当前证据,在基本情况下,我们假设小胆囊息肉患者的胆囊癌风险没有增加。为了估计通过监测获得的最大可能 LE 增益,我们假设通过 5 年的监测可以实现完美的癌症控制。我们在敏感性分析中改变了关键假设,包括癌症风险和检测性能特征。
在大多数评估的队列和情景中,监测带来的预期寿命增益小于 3 天。对于无合并症的 66 岁和 80 岁女性,LE 增益分别为 1.46 天和 1.45 天,男性则分别为 0.67 天和 0.75 天。如果进行 10 年的监测,无合并症的 66 岁女性的 LE 增益增加到 2.94 天(男性:1.35 天)。如果我们假设息肉患者的胆囊癌风险增加 10%,则无合并症的 66 岁女性的 LE 增益略有增加至 1.60 天(男性:0.74 天)。结果对检测性能和手术死亡率敏感。
即使在癌症控制的不切实际、乐观的假设下,偶然发现的小胆囊息肉的超声监测获益也有限。